Treating osteochondral cartilage defects still remains a challenge within the daily orthopaedic practice. Autologous osteochondral mosaicplasty is a one-step surgical technique that involves transplanting hyaline articular cartilage and subchondral bone from the minimal weight-bearing areas of the knee. This technique aims to restore focal, full-thickness articular cartilage defects and thus achieve a congruous hyaline surface.1 Scientific literature reports good long-term results in 72% of patients, with an overall failure rate of 28% and a reoperation rate of 19%.2
Mosaicplasty is known to yield several advantages. It is a one-step procedure, it can be applied to larger defects, providing both hyaline cartilage and subchondral bone, and has the capability to adapt according the defect geometry.1, 3 Moreover, it provides a durable cartilage repair, it is less expensive than autologous chondrocyte implantation/matrix-induced autologous chondrocyte implantation, and provides immediate restoration of cartilage surface by treating the entire osteochondral unit.4 Nevertheless, osteochondral graft harvesting is usually associated with donor site morbidity.5 To overcome this concern, a limited number of studies used autologous osteochondral grafts from the upper tibiofibular joint for the treatment of knee articular cartilage lesions.3, 6, 7, 8Therefore, this technical report aims to comprehensively describe the mosaicplasty technique using autologous osteochondral grafts from the upper tibiofibular joint.
http://www.arthroscopytechniques.org/article/S2212-6287(17)30253-0/fulltext








